Found 11 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m... |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Plasma kallikrein
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of PKL (unknown origin) using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured ... |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Urokinase-type plasminogen activator
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human uPA using fluorescent peptide as substrate by florescence assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Tissue-type plasminogen activator
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.68E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human tPa using fluorescent peptide as substrate by florescence assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 7.43E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human thrombin using fluorescent peptide as substrate by florescence assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Coagulation factor XI
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 8.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of N-terminal human plasma F11a catalytic domain expressed in Escherichia coli strain BL21(DE3) using D-Leu-Pro-Arg*Rh110-D-Pro as substra... |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human F7a using fluorescent peptide as substrate by florescence assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Coagulation factor IX
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.55E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human F9a using fluorescent peptide as substrate by florescence assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human F10a using fluorescent peptide as substrate by florescence assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Complement factor D
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.72E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human complement FD by TR-FRET assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |
Plasminogen
(Homo sapiens (Human)) | BDBM50542739
(CHEMBL4636760)Show SMILES COc1cccc(C(O)=O)c1OCC(O)c1cc(cc(c1)-c1ccc2OC[C@@H](N)c2c1)C(C)C |r| Show InChI InChI=1S/C27H29NO6/c1-15(2)17-9-18(16-7-8-24-21(12-16)22(28)13-33-24)11-19(10-17)23(29)14-34-26-20(27(30)31)5-4-6-25(26)32-3/h4-12,15,22-23,29H,13-14,28H2,1-3H3,(H,30,31)/t22-,23?/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of human plasmin using fluorescent peptide as substrate by florescence assay |
J Med Chem 63: 8088-8113 (2020)
Article DOI: 10.1021/acs.jmedchem.0c00279 BindingDB Entry DOI: 10.7270/Q2KS6W36 |
More data for this Ligand-Target Pair | |